Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics Inc (NQ: NRIX )

14.43 +0.62 (+4.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 608,460
Open 13.60
Bid (Size) 13.70 (1)
Ask (Size) 14.42 (2)
Prev. Close 13.81
Today's Range 13.58 - 14.76
52wk Range 7.520 - 37.42
Shares Outstanding 44,950,194
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
69 Biggest Movers From Friday
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... 
Via Benzinga
40 Stocks Moving In Friday's Mid-Day Session
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. 
Via Benzinga

Performance

YTD
-51.33%
-51.33%
1 Month
+36.26%
+36.26%
3 Month
+4.41%
+4.41%
6 Month
-48.00%
-48.00%
1 Year
-39.88%
-39.88%

More News

Read More
Analyst Ratings for Nurix Therapeutics
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022
Via Benzinga
10 Biggest Price Target Changes For Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
88 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Nurix Therapeutics Doses First Patient in Phase 1a/1b Study of NX-5948 For B-cell malignancies
Via Benzinga
Seagen CEO Clay Siegall Resigns After Domestic Violence Arrest
Via Investor's Business Daily
Nurix Therapeutics' BTK Programs Show Encouraging Preclinical Action In Blood Cancer, Solid Tumors
Via Benzinga
61 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
Via Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
Via Benzinga
Nurix Therapeutics: Q4 Earnings Insights
Via Benzinga
65 Biggest Movers From Yesterday
Via Benzinga
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street
Via Talk Markets
60 Biggest Movers From Yesterday
Via Benzinga
Why Nurix Therapeutics Stock Soared More Than 21% Wednesday
Via The Motley Fool
64 Biggest Movers From Yesterday
Via Benzinga
Why Did SVB Leerink Beef Up Target Price For Nurix Therapeutics?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.